カテゴリー： Market Monitor Global, 世界, 医療/バイオ

セルメチニブの世界市場見通し2023年-2029年

◆英語タイトル：Selumetinib Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8653 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：73 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Selumetinib Market 調査レポートは次の情報を含め、グローバルにおけるのセルメチニブ市場規模と予測を収録しています。・世界のセルメチニブ市場：売上、2018年-2023年、2024年-2029年
・世界のセルメチニブ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のセルメチニブ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「10mg」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

セルメチニブのグローバル主要企業は、AstraZeneca、 Merckなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、セルメチニブのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のセルメチニブ市場：タイプ別、2018年-2023年、2024年-2029年
世界のセルメチニブ市場：タイプ別市場シェア、2022年
・10mg、25mg

世界のセルメチニブ市場：用途別、2018年-2023年、2024年-2029年
世界のセルメチニブ市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のセルメチニブ市場：地域・国別、2018年-2023年、2024年-2029年
世界のセルメチニブ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるセルメチニブのグローバル売上、2018年-2023年
・主要企業におけるセルメチニブのグローバル売上シェア、2022年
・主要企業におけるセルメチニブのグローバル販売量、2018年-2023年
・主要企業におけるセルメチニブのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AstraZeneca、 Merck

*************************************************************

・調査・分析レポートの概要
セルメチニブ市場の定義
市場セグメント
世界のセルメチニブ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のセルメチニブ市場規模
世界のセルメチニブ市場規模：2022年 VS 2029年
世界のセルメチニブ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのセルメチニブの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のセルメチニブ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：10mg、25mg
セルメチニブのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
セルメチニブの用途別グローバル売上・予測

・地域別市場分析
地域別セルメチニブ市場規模 2022年と2029年
地域別セルメチニブ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AstraZeneca、 Merck
...

Koselugo (selumetinib) is inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK1/2). MEK1/2 proteins are upstream regulators of the extracellular signal-related kinase (ERK) pathway. Both MEK and ERK are critical components of the RAS-regulated RAF-MEK-ERK pathway, which is often activated in different types of cancers.
This report aims to provide a comprehensive presentation of the global market for Selumetinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Selumetinib. This report contains market size and forecasts of Selumetinib in global, including the following market information:
Global Selumetinib Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Selumetinib Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Selumetinib companies in 2022 (%)
The global Selumetinib market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
10 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Selumetinib include AstraZeneca and Merck etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Selumetinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Selumetinib Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Selumetinib Market Segment Percentages, by Type, 2022 (%)
10 mg
25 mg
Global Selumetinib Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Selumetinib Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Selumetinib Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Selumetinib Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Selumetinib revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Selumetinib revenues share in global market, 2022 (%)
Key companies Selumetinib sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Selumetinib sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Selumetinib, market overview.
Chapter 2: Global Selumetinib market size in revenue and volume.
Chapter 3: Detailed analysis of Selumetinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Selumetinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Selumetinib capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Selumetinib Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Selumetinib Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Selumetinib Overall Market Size
2.1 Global Selumetinib Market Size: 2022 VS 2029
2.2 Global Selumetinib Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Selumetinib Sales: 2018-2029
3 Company Landscape
3.1 Top Selumetinib Players in Global Market
3.2 Top Global Selumetinib Companies Ranked by Revenue
3.3 Global Selumetinib Revenue by Companies
3.4 Global Selumetinib Sales by Companies
3.5 Global Selumetinib Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Selumetinib Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Selumetinib Product Type
3.8 Tier 1, Tier 2 and Tier 3 Selumetinib Players in Global Market
3.8.1 List of Global Tier 1 Selumetinib Companies
3.8.2 List of Global Tier 2 and Tier 3 Selumetinib Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Selumetinib Market Size Markets, 2022 & 2029
4.1.2 10 mg
4.1.3 25 mg
4.2 By Type – Global Selumetinib Revenue & Forecasts
4.2.1 By Type – Global Selumetinib Revenue, 2018-2023
4.2.2 By Type – Global Selumetinib Revenue, 2024-2029
4.2.3 By Type – Global Selumetinib Revenue Market Share, 2018-2029
4.3 By Type – Global Selumetinib Sales & Forecasts
4.3.1 By Type – Global Selumetinib Sales, 2018-2023
4.3.2 By Type – Global Selumetinib Sales, 2024-2029
4.3.3 By Type – Global Selumetinib Sales Market Share, 2018-2029
4.4 By Type – Global Selumetinib Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Selumetinib Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Selumetinib Revenue & Forecasts
5.2.1 By Application – Global Selumetinib Revenue, 2018-2023
5.2.2 By Application – Global Selumetinib Revenue, 2024-2029
5.2.3 By Application – Global Selumetinib Revenue Market Share, 2018-2029
5.3 By Application – Global Selumetinib Sales & Forecasts
5.3.1 By Application – Global Selumetinib Sales, 2018-2023
5.3.2 By Application – Global Selumetinib Sales, 2024-2029
5.3.3 By Application – Global Selumetinib Sales Market Share, 2018-2029
5.4 By Application – Global Selumetinib Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Selumetinib Market Size, 2022 & 2029
6.2 By Region – Global Selumetinib Revenue & Forecasts
6.2.1 By Region – Global Selumetinib Revenue, 2018-2023
6.2.2 By Region – Global Selumetinib Revenue, 2024-2029
6.2.3 By Region – Global Selumetinib Revenue Market Share, 2018-2029
6.3 By Region – Global Selumetinib Sales & Forecasts
6.3.1 By Region – Global Selumetinib Sales, 2018-2023
6.3.2 By Region – Global Selumetinib Sales, 2024-2029
6.3.3 By Region – Global Selumetinib Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Selumetinib Revenue, 2018-2029
6.4.2 By Country – North America Selumetinib Sales, 2018-2029
6.4.3 US Selumetinib Market Size, 2018-2029
6.4.4 Canada Selumetinib Market Size, 2018-2029
6.4.5 Mexico Selumetinib Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Selumetinib Revenue, 2018-2029
6.5.2 By Country – Europe Selumetinib Sales, 2018-2029
6.5.3 Germany Selumetinib Market Size, 2018-2029
6.5.4 France Selumetinib Market Size, 2018-2029
6.5.5 U.K. Selumetinib Market Size, 2018-2029
6.5.6 Italy Selumetinib Market Size, 2018-2029
6.5.7 Russia Selumetinib Market Size, 2018-2029
6.5.8 Nordic Countries Selumetinib Market Size, 2018-2029
6.5.9 Benelux Selumetinib Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Selumetinib Revenue, 2018-2029
6.6.2 By Region – Asia Selumetinib Sales, 2018-2029
6.6.3 China Selumetinib Market Size, 2018-2029
6.6.4 Japan Selumetinib Market Size, 2018-2029
6.6.5 South Korea Selumetinib Market Size, 2018-2029
6.6.6 Southeast Asia Selumetinib Market Size, 2018-2029
6.6.7 India Selumetinib Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Selumetinib Revenue, 2018-2029
6.7.2 By Country – South America Selumetinib Sales, 2018-2029
6.7.3 Brazil Selumetinib Market Size, 2018-2029
6.7.4 Argentina Selumetinib Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Selumetinib Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Selumetinib Sales, 2018-2029
6.8.3 Turkey Selumetinib Market Size, 2018-2029
6.8.4 Israel Selumetinib Market Size, 2018-2029
6.8.5 Saudi Arabia Selumetinib Market Size, 2018-2029
6.8.6 UAE Selumetinib Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Selumetinib Major Product Offerings
7.1.4 AstraZeneca Selumetinib Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Selumetinib Major Product Offerings
7.2.4 Merck Selumetinib Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
8 Global Selumetinib Production Capacity, Analysis
8.1 Global Selumetinib Production Capacity, 2018-2029
8.2 Selumetinib Production Capacity of Key Manufacturers in Global Market
8.3 Global Selumetinib Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Selumetinib Supply Chain Analysis
10.1 Selumetinib Industry Value Chain
10.2 Selumetinib Upstream Market
10.3 Selumetinib Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Selumetinib Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Selumetinib in Global Market
Table 2. Top Selumetinib Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Selumetinib Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Selumetinib Revenue Share by Companies, 2018-2023
Table 5. Global Selumetinib Sales by Companies, (K Units), 2018-2023
Table 6. Global Selumetinib Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Selumetinib Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Selumetinib Product Type
Table 9. List of Global Tier 1 Selumetinib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Selumetinib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Selumetinib Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Selumetinib Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Selumetinib Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Selumetinib Sales (K Units), 2018-2023
Table 15. By Type - Global Selumetinib Sales (K Units), 2024-2029
Table 16. By Application – Global Selumetinib Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Selumetinib Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Selumetinib Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Selumetinib Sales (K Units), 2018-2023
Table 20. By Application - Global Selumetinib Sales (K Units), 2024-2029
Table 21. By Region – Global Selumetinib Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Selumetinib Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Selumetinib Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Selumetinib Sales (K Units), 2018-2023
Table 25. By Region - Global Selumetinib Sales (K Units), 2024-2029
Table 26. By Country - North America Selumetinib Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Selumetinib Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Selumetinib Sales, (K Units), 2018-2023
Table 29. By Country - North America Selumetinib Sales, (K Units), 2024-2029
Table 30. By Country - Europe Selumetinib Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Selumetinib Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Selumetinib Sales, (K Units), 2018-2023
Table 33. By Country - Europe Selumetinib Sales, (K Units), 2024-2029
Table 34. By Region - Asia Selumetinib Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Selumetinib Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Selumetinib Sales, (K Units), 2018-2023
Table 37. By Region - Asia Selumetinib Sales, (K Units), 2024-2029
Table 38. By Country - South America Selumetinib Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Selumetinib Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Selumetinib Sales, (K Units), 2018-2023
Table 41. By Country - South America Selumetinib Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Selumetinib Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Selumetinib Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Selumetinib Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Selumetinib Sales, (K Units), 2024-2029
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Selumetinib Product Offerings
Table 48. AstraZeneca Selumetinib Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Selumetinib Product Offerings
Table 52. Merck Selumetinib Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Selumetinib Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 55. Global Selumetinib Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Selumetinib Production by Region, 2018-2023 (K Units)
Table 57. Global Selumetinib Production by Region, 2024-2029 (K Units)
Table 58. Selumetinib Market Opportunities & Trends in Global Market
Table 59. Selumetinib Market Drivers in Global Market
Table 60. Selumetinib Market Restraints in Global Market
Table 61. Selumetinib Raw Materials
Table 62. Selumetinib Raw Materials Suppliers in Global Market
Table 63. Typical Selumetinib Downstream
Table 64. Selumetinib Downstream Clients in Global Market
Table 65. Selumetinib Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Selumetinib Segment by Type in 2022
Figure 2. Selumetinib Segment by Application in 2022
Figure 3. Global Selumetinib Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Selumetinib Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Selumetinib Revenue, 2018-2029 (US$, Mn)
Figure 7. Selumetinib Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Selumetinib Revenue in 2022
Figure 9. By Type - Global Selumetinib Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Selumetinib Revenue Market Share, 2018-2029
Figure 11. By Type - Global Selumetinib Sales Market Share, 2018-2029
Figure 12. By Type - Global Selumetinib Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Selumetinib Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Selumetinib Revenue Market Share, 2018-2029
Figure 15. By Application - Global Selumetinib Sales Market Share, 2018-2029
Figure 16. By Application - Global Selumetinib Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Selumetinib Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Selumetinib Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Selumetinib Revenue Market Share, 2018-2029
Figure 20. By Region - Global Selumetinib Sales Market Share, 2018-2029
Figure 21. By Country - North America Selumetinib Revenue Market Share, 2018-2029
Figure 22. By Country - North America Selumetinib Sales Market Share, 2018-2029
Figure 23. US Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Selumetinib Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Selumetinib Sales Market Share, 2018-2029
Figure 28. Germany Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 29. France Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Selumetinib Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Selumetinib Sales Market Share, 2018-2029
Figure 37. China Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 41. India Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Selumetinib Revenue Market Share, 2018-2029
Figure 43. By Country - South America Selumetinib Sales Market Share, 2018-2029
Figure 44. Brazil Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Selumetinib Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Selumetinib Sales Market Share, 2018-2029
Figure 48. Turkey Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Selumetinib Revenue, (US$, Mn), 2018-2029
Figure 52. Global Selumetinib Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Selumetinib by Region, 2022 VS 2029
Figure 54. Selumetinib Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ セルメチニブの世界市場見通し2023年-2029年(Selumetinib Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

セルメチニブの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp